Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...
After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...
The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...
Semaglutide (Ozempic) is 1 of 15 medications that will be included in yearly price negotiations between Medicare and ...
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing drugs, according to a new study.
The upcoming release of Phase III Fasenra data in COPD in 2025 is expected to solidify AstraZeneca’s position in the market.
AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...
Novo Nordisk's Ozempic and Wegovy are among 15 drugs targeted for Medicare price negotiations in 2027. The U.S. aims to cut ...
Learn how personalized exercise routines can transform your COPD journey, enhance resilience, and improve your quality of ...